Title : Low-dose decitabine priming endows CAR T cells with enhanced and persistent antitumour potential via epigenetic reprogramming.

Pub. Date : 2021 Jan 18

PMID : 33462245






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Herein, anti-tumour activities, cytokine production, and proliferation are enhanced in decitabine-treated chimeric antigen receptor T (dCAR T) cells both in vitro and in vivo. Decitabine carnation Drosophila melanogaster